Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Audit Finding: Change Control Linkage

GMP Risk from SOP Changes Without Corresponding Validation Updates

Posted on By

GMP Risk from SOP Changes Without Corresponding Validation Updates Ensuring SOP Changes Reflect Validation Data for GMP Compliance Introduction to the Audit Finding 1. What’s the Problem? Standard Operating Procedures (SOPs) are sometimes revised to reflect process changes or improvements. However, these changes may not be supported by corresponding validation activities — creating a gap…

Read More “GMP Risk from SOP Changes Without Corresponding Validation Updates” »

Change Control Linkage, GMP Audit Findings

GMP Risk from Inadequate Impact Assessment in Change Control SOP

Posted on By

GMP Risk from Inadequate Impact Assessment in Change Control SOP Why Impact Assessment Is Vital in Change Control SOPs Introduction to the Audit Finding 1. What Was Observed? In many audit reports, the change control SOP is found lacking clear, detailed steps for evaluating potential impact on validation, product quality, or regulatory status. 2. Why…

Read More “GMP Risk from Inadequate Impact Assessment in Change Control SOP” »

Change Control Linkage, GMP Audit Findings

Audit Risks from Delayed Closure of Change Control Records

Posted on By

Audit Risks from Delayed Closure of Change Control Records Addressing Delayed Change Control Closure in GMP Environments Introduction to the Audit Finding 1. What Was Observed? Change control records were found open well past the defined SOP closure period. This delay raised concerns regarding the effectiveness and responsiveness of the quality management system (QMS). 2….

Read More “Audit Risks from Delayed Closure of Change Control Records” »

Change Control Linkage, GMP Audit Findings

Risks of Missing SOP References in Change Control Records

Posted on By

Risks of Missing SOP References in Change Control Records Why Every Change Record Must Reference the Correct SOP Revision Introduction to the Audit Finding 1. What Was Observed? Change control records failed to explicitly mention the revised SOP number or version being impacted, updated, or implemented. 2. Why This Is a GMP Concern Creates ambiguity…

Read More “Risks of Missing SOP References in Change Control Records” »

Change Control Linkage, GMP Audit Findings

GMP Risks from Lack of Cross-Functional Review in Change Control

Posted on By

GMP Risks from Lack of Cross-Functional Review in Change Control Importance of Cross-Functional Review in Change Control Systems Introduction to the Audit Finding 1. What Was Observed? The change control process lacked a defined cross-functional review mechanism. Changes were initiated and approved within a single department without input from impacted teams. 2. Why This Is…

Read More “GMP Risks from Lack of Cross-Functional Review in Change Control” »

Change Control Linkage, GMP Audit Findings

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme